A cheap vaccine developed in India against rotavirus could add substantially to protection against diarrhoea.

Urgent action is needed to head off a cancer epidemic in Latin America and the Caribbean, warns an international group of specialists.

China and Africa are working on plans to offer African scientists training, carry out joint research and transfer technology.

Genome sequencing has revealed surprising new malaria parasites in Cambodia that are resistant to artemisinin, the frontline drug treatment.

A global plan to help reach the world's 22 million unvaccinated children may not be doing enough for developing nations, MSF says.

After a lengthy court battle, India has rejected a major cancer drug patent bid — meaning lifesaving drugs will remain cheap and accessible.

An analysis conducted in Latin America says that vaccinating high-risk groups against pneumococcal diseases would be more cost-effective than treating them.

Scientists from leading cancer centres are calling for the exchange of research findings as one recommendation for cutting cancer deaths.

Hopes of eliminating kala azar in South Asia are receding with the main drug used against the parasitic disease losing efficacy.

Global drug markets are awash with low quality medicine, partly because of inadequate testing in poor countries, says a US report.

Male circumcision does not lower the prevalence of HPV, the virus that causes cancer, according to a study in Latin America.

Start-up companies are demonstrating unmanned aerial vehicles that can deliver small payloads such as medical supplies to remote areas.

Strains of rotavirus earlier found only in animals are now infecting human beings.

Giving school teachers access to antiretroviral therapy could improve the quality of education and save money, a study has found.

While life expectancy worldwide has risen since 1990, Sub-Saharan Africa continues to lag far behind in key health areas, says a study.

The government of Zimbabwe has earmarked substantial funding to kick-start a nanotechnology programme focused on TB and HIV/AIDS.

Trials of a machine that can detect tuberculosis within two hours show that it is more accurate at diagnosing the disease than current test.

The world's largest drug firms have increased spending on drug access in developing countries, but face questions over clinical trial ethics.

New strains of the HIV1- C subtype are rapidly gaining in prevalence in India.